TRIPLE HELIX BIOTECHNOLOGY LTD

Executive Summary

Triple Helix Biotechnology Ltd is a start-up biotech company with a stable but modest asset base and low liabilities. The company is currently loss-making with a significant drop in cash reserves over the past year, highlighting liquidity risk. Credit approval is conditional on continued monitoring of cash flow, profitability improvements, and management’s ability to secure additional funding to support ongoing operations.

View Full Analysis Report →
Legal registered address
12 New Fetter Lane London United Kingdom EC4A 1JP Copied!

Latest financial results as of 14 September 2025
Cash in bank
£39.58k
Current assets
£59.75k
Fixed assets
£49.11k
Current creditors
£5.52k
Shareholders funds
£299.95k
View full financial accounts

Company number
13749240 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
Total Exemption Full
Incorporated on
17 November 2021
Accounts

Latest annual accounts were to 30 November 2023

Next annual accounts are due by 30 November 2025

Company financial year end is on 30 November 2025

Confirmation statement

Latest confirmation statement statement dated 16 November 2024

Next statement due by 30 November 2025

View original and historic source data
Nature of business (SIC)

72110 - Research and experimental development on biotechnology

Latest company documents
DateDescription
18/11/2418 November 2024 Confirmation statement made on 2024-11-16 with no updates

View Document

12/11/2412 November 2024 Change of details for Mr Zijie Wang as a person with significant control on 2024-09-15

View Document

12/11/2412 November 2024 Director's details changed for Mr Zijie Wang on 2024-09-15

View Document

06/11/246 November 2024 Change of details for Mr Da Lin as a person with significant control on 2021-11-24

View Document

25/10/2425 October 2024 Total exemption full accounts made up to 2023-11-30

View Document

View all company documents

More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company